Co–Editor-in-Chief

Kenneth E. Schmader, MD
Professor
Department of Medicine
Center for the Study of Aging and Human Development
Duke University Medical Center
Geriatric Research Education and Clinical Center
Durham VA Medical Center

Co–Editor-in-Chief

Joseph T. Hanlon, PharmD, MS
Professor, Division of Geriatric Medicine
Department of Medicine;
Division of Geriatric Medicine,
School of Pharmacy
University of Pittsburgh
Health Scientist, Center for Health Equity
Research and Promotion;
Geriatric Research Education and Clinical Center
VA Pittsburgh Healthcare System

Editor, Pharmacotherapy Reviews

Harold L. Kirschenbaum, PharmD
Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Long Island University

Contributing Editor

David R.P. Guay, PharmD
College of Pharmacy
University of Minnesota
HealthPartners, Inc.

Advisory Board

  • Kevin T. Bain, PharmD, MPH
    excelleRx, Inc., an Omnicare company
  • Arlene S. Bierman, MD, MS
    Ontario Women’s Health Council
    University of Toronto, Canada
  • Dan G. Blazer, MD, PhD
    Duke University Medical Center
  • A. John Campbell, MD, FRACP
    Faculty of Medicine
    University of Otago Medical School
    New Zealand
  • Nicholas G. Castle, PhD
    Health Policy & Management
    Graduate School of Public Health
    University of Pittsburgh
  • James W. Cooper, PhD
    College of Pharmacy
    University of Georgia
  • Barry J. Cusack, MD
    Geriatric Research Education
      and Clinical Center
    Idaho VA Medical Center
  • Maurice W. Dysken, MD
    University of Minnesota Medical School
    Geriatric Research Education
      and Clinical Center
    Minneapolis VA Medical Center
  • E. Wesley Ely, MD, MPH
    Health Service Research Center
    Vanderbilt University
      School of Medicine
    Geriatric Research Education
      and Clinical Center
    Tennessee Valley Healthcare System
  • Gerda G. Fillenbaum, PhD
    Center for the Study of Aging and Human Development
    Duke University Medical Center
  • Howard M. Fillit, MD
    The Institute for the Study of Aging, New York
  • Paul Gallagher, MB MRCPI
    St. James’s Hospital
    Ireland
  • Shelly L. Gray, PharmD, MS
    School of Pharmacy
    University of Washington
  • Sarah Hilmer, BScMed (Hons), MBBS (Hons), FRACP, PhD
    Royal North Shore Hospital and University of Sydney
    Australia
  • Marie-Laure Laroche, MD, PhD
    Centre Régional de Pharmacovigilance
    Hôpital Dupuytren–Centre Hospitalier Universitaire
    France
  • Kenneth W. Lyles, MD
    Center for the Study of Aging
      and Human Development
    Duke University Medical Center
    Geriatric Research Education
      and Clinical Center
    Durham VA Medical Center
  • Alison A. Moore, MD, MPH
    David Geffen School of Medicine
    University of California, Los Angeles
  • C. Alice Oborne, PhD, MSc, Clin Pharm
    Medicine Use Research
    St. Thomas’ Hospital Pharmacy
    United Kingdom
  • Subashan Perera, PhD
    Division of Geriatric Medicine
    Department of Biostatistics
    University of Pittsburgh
  • Carl F. Pieper, DrPH
    Center for the Study of Aging
      and Human Development
    Duke University Medical Center
  • Bruce G. Pollock, MD, PhD
    Department of Psychiatry
    Baycrest Centre for Geriatric Care
    University of Toronto
    Canada
  • Paula A. Rochon, MD
    Kunin Lunenfeld Applied Research Unit
    Baycrest Centre for Geriatric Care
    University of Toronto
    Institute for Clinical Evaluative Sciences
    Canada
  • Todd P. Semla, PharmD, MS
    Prescription Benefits Management
    The Feinberg School of Medicine
    Northwestern University
  • Ronald I. Shorr, MD, MS
    Geriatric Research Education and Clinical Center
    North Florida/South Georgia Veterans Health System
    Department of Aging & Geriatric Research
    University of Florida
  • Patricia W. Slattum, PharmD, PhD
    School of Pharmacy
    Virginia Commonwealth University
  • Michael A. Steinman, MD
    Division of Geriatrics, Department of Medicine
    University of California, San Francisco
    HSR&D Research Enhancement Award Program
    San Francisco VA Medical Center
  • Bruce Stuart, PhD
    Peter Lamy Center on Drug Therapy
      and Aging
    University of Maryland
  • Stephanie A. Studenski, MD, MPH
    Division of Geriatric Medicine
    University of Pittsburgh
    School of Medicine
  • Cameron Swift, PhD
    Department of Health Care of the Elderly
    Guy’s, King’s and St. Thomas’ School of Medicine
    United Kingdom
  • Morris Weinberger, PhD
    Health Policy and Administration
    University of North Carolina
      at Chapel Hill
    Center for Health Services Research
      in Primary Care
    Durham VA Medical Center
  • Debra K. Weiner, MD
    Older Adult Pain Management Program
    University of Pittsburgh
    School of Medicine


Acknowledgments

  • Dr. Kevin T. Bain—No financial relationships with commercial interests.
  • Dr. Arlene S. Bierman—No financial relationships with commercial interests.
  • Dr. Dan G. Blazer—No financial relationships with commercial interests.
  • Dr. A. John Campbell—No financial relationships with commercial interests.
  • Dr. Nicholas G. Castle—No financial relationships with commercial interests.
  • Dr. James W. Cooper, Jr.Consultant: Abbott, AstraZeneca, Aventis, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Ciba-Geigy, Marion-Merrell-Dow, Merck, Janssen, GlaxoSmithKline, Lederle, Pfizer-Roerig, Proctor and Gamble, Ortho-McNeill, Purdue-Pharma, Lilly-Dista, Merck, Organon, Roxane, Forest, Upjohn-Pharmacia, Watson Labs, Novartis
  • Dr. Barry Cusack—No financial relationships with commercial interests.
  • Dr. Maurce W. Dysken—No financial relationships with commercial interests.
  • Dr. E. Wesley ElyConsultant, Grants, Honoraria: Pfizer, Hospira, GlaxoSmithKline, Aspect.
  • Dr. Gerda G. Fillenbaum—No financial relationships with commercial interests.
  • Dr. Howard M. FillitConsultant: Pfizer, Elan, Janssen AI, Avid, Bayer, sanofi-aventis.
  • Dr. Paul Gallagher—No financial relationships with commercial interests.
  • Dr. Shelly L. Gray—No financial relationships with commercial interests.
  • Dr. David R.P. Guay—No financial relationships with commercial interests.
  • Dr. Joseph T. Hanlon—No financial relationships with commercial interests.
  • Dr. Sarah HilmerPatent holder: Drug Burden Index.
  • Dr. Harold L. Kirschenbaum—No financial relationships with commercial interests.
  • Dr. Marie-Laure Laroche—No financial relationships with commercial interests.
  • Dr. Kenneth W. LylesConsultant: Novartis, Procter & Gamble, Merck, Amgen, Kirin Pharmaceutical, GTx, Eli Lilly, GlaxoSmithKline, Bone Medical Ltd., Wyeth, Osteologix; Research Support: Novartis, Alliance for Better Bone Health, Amgen; Patent Inventor: “Medication Kits and Formulations for Preventing, Treating or Reducing Secondary Fractures After Previous Fracture”; Use Patent Co-Inventor: “Methods for Preventing or Reducing Secondary Fractures After Hip Fracture”, US Patent 20050272707; Provisional Patent Application Co-Inventor: “Bisphosphonates and Mortality Reduction.”
  • Dr. Alison A. Moore—No financial relationships with commercial interests.
  • Dr. C. Alice Oborne—No financial relationships with commercial interests.
  • Dr. Subashan Perera—No financial relationships with commercial interests.
  • Dr. Carl F. Pieper—No financial relationships with commercial interests.
  • Dr. Bruce G. PollockResearch Support: Sandra A. Rotman Program and Chair, The National Institute of Health, The Canadian Institutes of Health Research; Advisory Board Member: Lundbeck Canada; Consultant: Wyeth; Faculty Member: Lundbeck International Neuroscience Foundation (LINF).
  • Dr. Paula Rochon—No financial relationships with commercial interests.
  • Dr. Kenneth E. SchmaderConsultant: GlaxoSmithKline, Merck; Grants: Pfizer, Wyeth, Merck.
  • Dr. Todd P. Semla—No financial relationships with commercial interests.
  • Dr. Ronald I. Shorr—No financial relationships with commercial interests.
  • Dr. Patricia W. Slattum—No financial relationships with commercial interests.
  • Dr. Michael A. Steinman—No financial relationships with commercial interests.
  • Dr. Bruce StuartGrant Funding: Novartis, GlaxoSmithKline.
  • Dr. Stephanie A. StudenskiConsultant: Merck, Novartis, GTx, GlaxoSmithKline.
  • Dr. Cameron G. Swift—No financial relationships with commercial interests.
  • Dr. Morris Weinberger—No financial relationships with commercial interests.
  • Dr. Debra K. Weiner—No financial relationships with commercial interests.